Yahoo Finance

Perrigo, founded in 1887, is a leading manufacturer of generic over-the-counter healthcare products and supplier of infant formulas for the store-brand market. Perrigo's private-label consumer products encompass a variety of cold/allergy, gastrointestinal, first aid, motion sickness, vitamin, smoking cessation, and other remedies. The company has a market cap of approximately $4 billion after divesting its RX pharmaceutical business in 2021. Headquartered in Dublin, Ireland, Perrigo has over 8,300 employees.

Stocks are up at midday. The major indices are all higher by about 1%. Wall Street is showing relief that President Trump has given a tariff reprieve to certain electronics. Meanwhile, more big banks are warning that tariffs will hurt profit earnings growth. Citigroup and Morgan Stanley lowered their forecasts for the year. The yield on the 10-year Treasury note is 4.41%. Oil is at $62 per barrel. Bitcoin is near $85,000.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

One way to make lemonade from lemons in a broad stock-market pullback is to weed out the losers from an investment portfolio, harvesting tax-loss carryforwards along the way. These losses can be used to offset future capital gains that may be generated when the stock market once again is in an uptrend. It takes discipline to sell stocks, however. Many times, investors are reluctant to sell stocks that are down in the dumps due to hopes that a turnaround is coming. In this case, an alternative strategy can be to sell losers and buy a similar stock or related industry ETF in an attempt to capture upside down the road. But beware of the tax rules. The so-called wash-sale rule from the IRS prohibits selling an investment for a loss and replacing it with the same or "substantially identical" investment 30 days before or after the sale. Here's a list of stocks on the Argus HOLD list that have fallen the farthest from their 52-week highs and could be tax-loss candidates.